LAIV

Genentech recalls psoriasis drug Raptiva on concerns of fatal brain infection Tovaxin keeps multiple scelorosis patients relapse-free, says Opexa Rituximab (Rituxan) plus methotrexate combo denied approval for rheumatoid arthritis treatment High-dose flu vaccine Fluzone for elderly approved by US FDA: Sanofi Pasteur H1N1 swine flu nasal spray vaccine (LAIV) recalled in US by AstraZeneca's MedImmune

DWS Full News Feed pillscribe 2010

Genentech recalls psoriasis drug Raptiva on concerns of fatal brain infection Tovaxin keeps multiple scelorosis patients relapse-free, says Opexa Rituximab (Rituxan) plus methotrexate combo denied approval for rheumatoid arthritis treatment High-dose flu vaccine Fluzone for elderly approved by US FDA: Sanofi Pasteur H1N1 swine flu nasal spray vaccine (LAIV) recalled in US by AstraZeneca's MedImmune

DWS Full News Feed 2010

Live attenuated influenza vaccine (LAIV), however, is only cost effective through November.

Healthcare Economist Jason Shafrin 2010

Safer yellow fever vaccine is currently in clinical studies: Xcellerex Gardasil prevents cervical, vaginal cancers in women of 27-45 age group too: Merck H1N1 swine flu nasal spray vaccine (LAIV) recalled in US by AstraZeneca's MedImmune

DWS Pill Scribe pillscribe 2010

Genentech recalls psoriasis drug Raptiva on concerns of fatal brain infection Tovaxin keeps multiple scelorosis patients relapse-free, says Opexa Rituximab (Rituxan) plus methotrexate combo denied approval for rheumatoid arthritis treatment High-dose flu vaccine Fluzone for elderly approved by US FDA: Sanofi Pasteur H1N1 swine flu nasal spray vaccine (LAIV) recalled in US by AstraZeneca's MedImmune

DWS Full News Feed 2010

Genentech recalls psoriasis drug Raptiva on concerns of fatal brain infection Tovaxin keeps multiple scelorosis patients relapse-free, says Opexa Rituximab (Rituxan) plus methotrexate combo denied approval for rheumatoid arthritis treatment High-dose flu vaccine Fluzone for elderly approved by US FDA: Sanofi Pasteur H1N1 swine flu nasal spray vaccine (LAIV) recalled in US by AstraZeneca's MedImmune

DWS Full News Feed pillscribe 2010

Nobilon, the human vaccine business unit of Schering-Plough Corporation has announced that it has reached an important milestone with the initiation of its first-in-human clinical development program for SCH 900795, a new intranasal Live Attenuated Influenza Vaccine (LAIV) for annual seasonal use.

THE MEDICAL NEWS 2009

The LAIV differs from most existing influenza vaccines, because it has been designed to offer (1) single-dose intranasal delivery, (2) advanced cell culture manufacturing technology and (3) potential earlier and broader protection against infection by influenza viruses.

THE MEDICAL NEWS 2009

Context Since 2004, increasing numbers of military personnel have been immunized with the intranasal live attenuated influenza vaccine (LAIV) while most others received the trivalent inactivated vaccine (TIV).

JAMA current issue 2009

Moreover, Live Attenuated Influenza Vaccine (LAIV) is expected to be more effective in inducing local and cellular immunity and as such may be more efficacious in eliciting protection.

THE MEDICAL NEWS 2009